Eastgate Biotech Corp
OTC:ETBI
Eastgate Biotech Corp
OTC:ETBI
Price:
0.005
USD
Market Closed
Market Cap:
$3.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eastgate Biotech Corp
OTC:ETBI
|
CA |
|
R
|
Ralco Corporation Bhd
KLSE:RALCO
|
MY |
|
Luca Mining Corp
F:Z68
|
CA |
|
A
|
Arkema SA
XMUN:V1S
|
FR |
|
K
|
Kyowa Kirin Co Ltd
DUS:KY4
|
JP |
|
Lautan Luas Tbk PT
IDX:LTLS
|
ID |
|
Alstom SA
F:AOMU
|
FR |
|
K
|
Korea Arlico Pharm Co Ltd
KOSDAQ:260660
|
KR |
|
Seino Holdings Co Ltd
OTC:SEOTF
|
JP |
Intrinsic Value
Not Available for ETBI
There is not enough data to reliably calculate the intrinsic value for Eastgate Biotech Corp.
Do our valuations actually work? See backtest results .
Alternatives to ETBI
Fundamental Analysis
What Eastgate Biotech Does
Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-01-16. The firm utilizes nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives.
- Headquarters
- Canada CA
- IPO date
- Jan 16, 2014
Financials
Revenue & Expenses Breakdown
Eastgate Biotech Corp
Eastgate Biotech Corp
Efficiency
Earnings Waterfall
Eastgate Biotech Corp
Eastgate Biotech Corp
